233 related articles for article (PubMed ID: 21440326)
21. Foamy virus--adenovirus hybrid vectors.
Picard-Maureau M; Kreppel F; Lindemann D; Juretzek T; Herchenröder O; Rethwilm A; Kochanek S; Heinkelein M
Gene Ther; 2004 Apr; 11(8):722-8. PubMed ID: 14724670
[TBL] [Abstract][Full Text] [Related]
22. Replication and packaging of helper-dependent adenoviral vectors.
Sato M; Suzuki S; Kubo S; Mitani K
Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
[TBL] [Abstract][Full Text] [Related]
23. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
Kojima H; Ohishi N; Yagi K
Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
[TBL] [Abstract][Full Text] [Related]
24. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication.
Krougliak VA; Krougliak N; Eisensmith RC
J Gene Med; 2001; 3(1):51-8. PubMed ID: 11269336
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated gene therapy of liver diseases.
Ilan Y; Saito H; Thummala NR; Chowdhury NR
Semin Liver Dis; 1999; 19(1):49-59. PubMed ID: 10349683
[TBL] [Abstract][Full Text] [Related]
27. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.
Kreppel F; Luther TT; Semkova I; Schraermeyer U; Kochanek S
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1965-70. PubMed ID: 12037006
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
Robinson M; Ge Y; Ko D; Yendluri S; Laflamme G; Hawkins L; Jooss K
Cancer Gene Ther; 2008 Jan; 15(1):9-17. PubMed ID: 17853920
[TBL] [Abstract][Full Text] [Related]
29. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
[TBL] [Abstract][Full Text] [Related]
30. Increased protein expression from adenoviral shuttle plasmids and vectors by insertion of a small chimeric intron sequence.
Hermening S; Kügler S; Bähr M; Isenmann S
J Virol Methods; 2004 Dec; 122(1):73-7. PubMed ID: 15488623
[TBL] [Abstract][Full Text] [Related]
31. Vector systems for prenatal gene therapy: principles of adenovirus design and production.
Alba R; Baker AH; Nicklin SA
Methods Mol Biol; 2012; 891():55-84. PubMed ID: 22648768
[TBL] [Abstract][Full Text] [Related]
32. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.
Steinwaerder DS; Lieber A
Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570
[TBL] [Abstract][Full Text] [Related]
33. Transduction of adenovirus vectors modified with cell-penetrating peptides.
Eto Y; Yoshioka Y; Asavatanabodee R; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Peptides; 2009 Aug; 30(8):1548-52. PubMed ID: 19467282
[TBL] [Abstract][Full Text] [Related]
34. A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase.
Ehrhardt A; Xu H; Huang Z; Engler JA; Kay MA
Mol Ther; 2005 May; 11(5):695-706. PubMed ID: 15851008
[TBL] [Abstract][Full Text] [Related]
35. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
36. Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors.
Ohbayashi F; Balamotis MA; Kishimoto A; Aizawa E; Diaz A; Hasty P; Graham FL; Caskey CT; Mitani K
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13628-33. PubMed ID: 16174752
[TBL] [Abstract][Full Text] [Related]
37. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
[TBL] [Abstract][Full Text] [Related]
38. Adenoviral vectors for gene transfer and therapy.
Volpers C; Kochanek S
J Gene Med; 2004 Feb; 6 Suppl 1():S164-71. PubMed ID: 14978759
[TBL] [Abstract][Full Text] [Related]
39. Adenoviral vectors for liver-directed gene therapy.
Connelly S
Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
[TBL] [Abstract][Full Text] [Related]
40. Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.
Ehrhardt A; Xu H; Kay MA
J Virol; 2003 Jul; 77(13):7689-95. PubMed ID: 12805471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
